课题基金 / 基金详情

FcRn-dependent sorting of IgG and IgG-opsinized antigens by epithelial cells

FcRn-dependent sorting of IgG and IgG-opsinized antigens by epithelial cells
上皮细胞对 IgG 和 IgG 视蛋白化抗原的 FcRn 依赖性分选
批准号:
8322163
负责人:
WAYNE I LENCER
金额:
$37.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2014-08-31

项目摘要

项目成果

WAYNE I LENCER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请方提供):本项目的总体目标是阐明IgG MHC I类Fc 3受体FcRn如何将IgG和IgG调理抗原转运进入和穿过肠屏障。上皮细胞中FcRn对IgG和相关IgG-复合物的运输对宿主和肠道微生物群落之间的对话具有重要影响,并因此对粘膜表面的上皮维持、炎症反应和宿主防御具有重要影响。我们将测试假设:1)肠上皮细胞利用FcRn来中和IgG调理的微生物和微生物产物并引起炎症反应; 2)与共同/顶端再循环内体(极化上皮细胞特有的区室)相关的特异性细胞因子调节FcRn的运输;和3)FcRn-胞质尾区中的膜近端两亲基序感知(或诱导)膜曲率或表面电位,从而影响受体运输。AIM 1将表征IgG调理颗粒如何将FcRn从代表FcRn运输的转胞吞和再循环途径转移至降解途径。我们还将使用胞质尾区突变的FcRn同种型检查该分选步骤中FcRn胞质尾区的结构-功能关系。AIM 2将跟进我们最近的研究中提出的想法,这些研究表明小GTTRab 25调节指定转胞吞的分选步骤。我们的目的是确定和表征的共同/顶端再循环内体,调节FcRn贩运极化细胞的细胞因子。待研究的蛋白质包括Rab 11 a/Rab 25效应子的FIP家族、Rab 10、Rab 8、ACAP 1和外囊复合物。我们将尝试使用酵母双杂交系统对FcRn相互作用蛋白进行无偏筛选,并且我们将检查顶端和基底侧膜SNARE,以查看这些分子是否标记含FcRn的囊泡用于跨极化细胞的矢量运输。AIM 3将聚焦于FcRn胞质尾区的膜近端区域,以测试通过感测(或诱导)膜曲率或表面电位的两亲性1-螺旋结构域分选膜蛋白的新想法。我们建议,寡聚化的这个主题解释了如何FcRn可以内化IgG调理颗粒和开关的贩运途径远离回收和转胞吞到降解隔间。公共卫生相关性:我们的目标是了解肠道与位于肠腔(腔)中的庞大而复杂的微生物菌群和微生物产物相互作用的一种方式。肠腔中的微生物与健康和疾病中的肠道功能调节密切相关,包括慢性炎症性肠病。在这里,我们研究了肠道受体如何转运免疫球蛋白G(人体中最主要的抗体形式)决定这种相互作用的结果。
英文摘要
DESCRIPTION (provided by applicant): The overarching goal of this project is to elucidate how the IgG MHC Class I-like Fc3-receptor FcRn transports IgG and IgG-opsonized antigens into and across the intestinal barrier. Trafficking of IgG and associated IgG- complexes by FcRn in epithelial cells has important consequences on the dialogue between host and commensal microflora, and thus on epithelial maintenance, inflammatory responses and host defense at mucosal surfaces. We will test the hypotheses: 1) that intestinal epithelial cells utilize FcRn to neutralize IgG- opsonized microbes and microbial products and to raise an inflammatory response; 2) that specific cellular factors associated with the common/apical recycling endosome, a compartment unique to polarized epithelial cells, regulate the trafficking of FcRn; and 3) that a membrane proximal amphipathic motif in the FcRn- cytoplasmic tail senses (or induces) membrane curvature or surface potential so as to affect receptor trafficking. AIM 1 will characterize how IgG-opsonized particles divert FcRn from the transcytotic and recycling pathways, which typify FcRn trafficking, into the degradative pathway. We also will examine structure-function relationships of the FcRn cytoplasmic tail in this sorting step using FcRn-isoforms mutated in its cytoplasmic tail domain. AIM 2 will follow-up on ideas raised in our recent studies indicating that the small GTPase Rab25 regulates a sorting step that specifies transcytosis. We aim to identify and characterize the cellular factors of the common/apical recycling endosomes that regulate FcRn trafficking in polarized cells. Proteins to be studied include the FIP family of Rab11a/Rab25 effectors, Rab10, Rab8, ACAP1, and the exocyst complex. We will attempt an unbiased screen for FcRn-interacting proteins using a yeast two-hybrid system, and we will examine the apical and basolateral membrane SNAREs to see if these molecules mark FcRn-containing vesicles for vectorial transport across polarized cells. AIM 3 will focus on the membrane proximal region of the FcRn cytoplasmic tail to test a new idea for sorting of membrane proteins by amphipathic 1-helical domains that sense (or induce) membrane curvature or surface potential. We propose that oligomerization of this motif explains how FcRn can internalize IgG-opsonized particles and switch pathways of trafficking away from recycling and transcytosis into degradative compartments. PUBLIC HEALTH RELEVANCE: We aim to understand one way that the intestine interacts with the vast and complex microflora and microbial products located in the intestinal lumen (cavity). Microbes in the intestinal lumen are strongly implicated in regulating intestinal function in health and disease, including the chronic inflammatory bowel diseases. Here, we study how an intestinal receptor for transporting immunoglobulin G (the most dominant form of antibodies in humans) dictates the outcome of this interaction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
  • 批准号:
    10214604
  • 项目类别:
  • 资助金额:
    $51.69万
  • 财政年份:
    2020
  • 负责人:
    WAYNE I LENCER
  • 依托单位:
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
  • 批准号:
    10626015
  • 项目类别:
  • 资助金额:
    $49.24万
  • 财政年份:
    2020
  • 负责人:
    WAYNE I LENCER
  • 依托单位:
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
  • 批准号:
    10405643
  • 项目类别:
  • 资助金额:
    $49.24万
  • 财政年份:
    2020
  • 负责人:
    WAYNE I LENCER
  • 依托单位:
Intestinal Disease-enterocyte toxin interaction
  • 批准号:
    9263933
  • 项目类别:
  • 资助金额:
    $71.69万
  • 财政年份:
    2016
  • 负责人:
    WAYNE I LENCER
  • 依托单位:
海外基金